Keywords: boeh, ingelheim, files, nda, tipranavir, germany, boehringer

Boeh Ingelheim files NDA for tipranavir

Article | 01 November 2004

Print This

Germany's Boehringer Ingelheim has submitted a New Drug Application to the US Food and Drug Administration for the use of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in